发明名称 |
Osteoclast Inhibitors for Knee Conditions |
摘要 |
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions. |
申请公布号 |
US2016113950(A1) |
申请公布日期 |
2016.04.28 |
申请号 |
US201514967234 |
申请日期 |
2015.12.11 |
申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot;Jones Graeme |
分类号 |
A61K31/675;A61K31/663 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating knee pain comprising:
a. selecting a patient having knee pain, and:
i. OARSI Grade 0 or Kellgren and Lawrence Grade 0 or Grade 1 of joint space narrowing, orii. pain intensity of 5 or greater measured using the 0-10 NRS or 5 cm or greater using the 10 cm VAS; and b. administering an inhibitor of osteoclast activity to the patient wherein the inhibitor of osteoclast activity is ibandronic acid or risedronic acid. |
地址 |
New York NY US |